ENDURANT CAPITAL MANAGEMENT LP Holdings

ENDURANT CAPITAL MANAGEMENT LP is an investment fund managing more than 307.05M US dollars. The largest holdings include INVACARE CORP, Laboratory Corporation of America Holdings and Humana. In Q3 2022 the fund bought assets of total value of 137.3M US dollars and sold assets of total value of 90.68M US dollars.

$307.04M

portfolio value

-4.21%

quarter

-19.02%

1 year

+33.11%

3 years

+32.09%

5 years

ENDURANT CAPITAL MANAGEMENT LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	65700000	56560000
Q2 2016	75764000	84295000
Q3 2016	62118000	86494000
Q4 2016	62629000	70867000
Q1 2017	124495000	50381000
Q2 2017	109493000	72215000
Q3 2017	102441000	127020000
Q4 2017	101077000	102776000
Q1 2018	82911000	138734000
Q2 2018	53788000	90716000
Q3 2018	90528000	89521000
Q4 2018	74023000	103215000
Q1 2019	146712000	90224000
Q2 2019	118503000	102451000
Q3 2019	127910000	110067000
Q4 2019	161910000	111226000
Q1 2020	92482000	183023000
Q2 2020	116276000	99964000
Q3 2020	141596000	77167000
Q4 2020	117343000	129543000
Q1 2021	180991000	69523000
Q2 2021	157720000	185042000
Q3 2021	96005000	146072000
Q4 2021	153681000	116054000
Q1 2022	108984000	143993000
Q2 2022	88247000	156914000
Q3 2022	137298000	90682000

ENDURANT CAPITAL MANAGEMENT LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
INVACARE CORP Portfolio share: 15.98% Portfolio value: 49.06M Avg. open price: N/A Current price: N/A P/L: N/A Bought +51.01% shares Q3 2021	share	15.98%	49.06M	N/A	N/A	N/A	Bought +51.01% shares Q3 2021
Diagnostics & Research Laboratory Corporation of America Holdings Portfolio share: 6.49% Portfolio value: 19.91M Avg. open price: $204.42 Current price: $236.39 P/L: +15.64% Bought +180.10% shares Q3 2022	share	6.49%	19.91M	$204.42	$236.39	+15.64%	Bought +180.10% shares Q3 2022
Healthcare Plans Humana Inc. Portfolio share: 5.17% Portfolio value: 15.88M Avg. open price: $443.4 Current price: $547.42 P/L: +23.46% Bought +20.74% shares Q3 2022	share	5.17%	15.88M	$443.4	$547.42	+23.46%	Bought +20.74% shares Q3 2022
Drug Manufacturers—Specialty & Generic Takeda Pharmaceutical Company Limited Portfolio share: 4.66% Portfolio value: 14.29M Avg. open price: $18.96 Current price: $14.56 P/L: -23.20% N/A Q3 2022	share	4.66%	14.29M	$18.96	$14.56	-23.20%	N/A Q3 2022
Medical Instruments & Supplies Baxter International Inc. Portfolio share: 4.30% Portfolio value: 13.20M Avg. open price: $63.01 Current price: $51.3 P/L: -18.58% Bought +172.74% shares Q3 2022	share	4.30%	13.20M	$63.01	$51.3	-18.58%	Bought +172.74% shares Q3 2022
Diagnostics & Research Qiagen N.V. Portfolio share: 4.09% Portfolio value: 12.54M Avg. open price: $49 Current price: $49.18 P/L: +0.37% Sold -23.68% shares Q3 2022	share	4.09%	12.54M	$49	$49.18	+0.37%	Sold -23.68% shares Q3 2022
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 4.03% Portfolio value: 12.38M Avg. open price: N/A Current price: $369.29 P/L: N/A N/A Q3 2022	share	4.03%	12.38M	N/A	$369.29	N/A	N/A Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 4.01% Portfolio value: 12.32M Avg. open price: $83.04 Current price: $103.53 P/L: +24.68% Bought +459.67% shares Q3 2022	share	4.01%	12.32M	$83.04	$103.53	+24.68%	Bought +459.67% shares Q3 2022
Diagnostics & Research ICON Public Limited Company Portfolio share: 3.98% Portfolio value: 12.21M Avg. open price: $149.67 Current price: $204.76 P/L: +36.80% Bought +33.63% shares Q3 2022	share	3.98%	12.21M	$149.67	$204.76	+36.80%	Bought +33.63% shares Q3 2022
Drug Manufacturers—General Bristol-Myers Squibb Company Portfolio share: 3.67% Portfolio value: 11.28M Avg. open price: $51.26 Current price: $80.7 P/L: +57.42% N/A Q3 2022	share	3.67%	11.28M	$51.26	$80.7	+57.42%	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Catalent, Inc. Portfolio share: 3.30% Portfolio value: 10.13M Avg. open price: $26.81 Current price: $50.77 P/L: +89.35% N/A Q3 2022	share	3.30%	10.13M	$26.81	$50.77	+89.35%	N/A Q3 2022
Healthcare Plans CIGNA CORP NEW Portfolio share: 3.08% Portfolio value: 9.46M Avg. open price: $170.13 Current price: $327.39 P/L: +92.44% Sold -15.54% shares Q3 2022	share	3.08%	9.46M	$170.13	$327.39	+92.44%	Sold -15.54% shares Q3 2022
REIT—Healthcare Facilities Omega Healthcare Investors, Inc. Portfolio share: 3.01% Portfolio value: 9.25M Avg. open price: N/A Current price: $29.64 P/L: N/A N/A Q3 2022	share	3.01%	9.25M	N/A	$29.64	N/A	N/A Q3 2022
INVACARE CORP Portfolio share: 2.75% Portfolio value: 8.43M Avg. open price: N/A Current price: N/A P/L: N/A Bought +44.24% shares Q4 2021	share	2.75%	8.43M	N/A	N/A	N/A	Bought +44.24% shares Q4 2021
Medical Devices Aziyo Biologics, Inc. Portfolio share: 2.67% Portfolio value: 8.20M Avg. open price: $11.5 Current price: $3.61 P/L: -68.64% Bought +0.60% shares Q3 2022	share	2.67%	8.20M	$11.5	$3.61	-68.64%	Bought +0.60% shares Q3 2022
Medical Instruments & Supplies Becton, Dickinson and Company Portfolio share: 2.49% Portfolio value: 7.63M Avg. open price: $201.5 Current price: $246.21 P/L: +22.19% N/A Q3 2022	share	2.49%	7.63M	$201.5	$246.21	+22.19%	N/A Q3 2022
Healthcare Plans Elevance Health Inc. Portfolio share: 2.43% Portfolio value: 7.45M Avg. open price: N/A Current price: $522.34 P/L: N/A N/A Q3 2022	share	2.43%	7.45M	N/A	$522.34	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Zoetis Inc. Portfolio share: 2.14% Portfolio value: 6.56M Avg. open price: $110.31 Current price: $155.33 P/L: +40.81% Bought +7.75% shares Q3 2022	share	2.14%	6.56M	$110.31	$155.33	+40.81%	Bought +7.75% shares Q3 2022
Biotechnology Selecta Biosciences, Inc. Portfolio share: 2.10% Portfolio value: 6.45M Avg. open price: $2.77 Current price: $1.31 P/L: -52.79% Sold -14.60% shares Q3 2022	share	2.10%	6.45M	$2.77	$1.31	-52.79%	Sold -14.60% shares Q3 2022
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 1.80% Portfolio value: 5.54M Avg. open price: $48.68 Current price: $68.42 P/L: +40.54% N/A Q3 2022	share	1.80%	5.54M	$48.68	$68.42	+40.54%	N/A Q3 2022
Medical Distribution McKesson Corporation Portfolio share: 1.79% Portfolio value: 5.49M Avg. open price: $146.66 Current price: $382.44 P/L: +160.76% Bought +1.15% shares Q3 2022	share	1.79%	5.49M	$146.66	$382.44	+160.76%	Bought +1.15% shares Q3 2022
Biotechnology Ocular Therapeutix, Inc. Portfolio share: 1.44% Portfolio value: 4.41M Avg. open price: $7.95 Current price: $2.99 P/L: -62.37% Bought +40.00% shares Q3 2022	share	1.44%	4.41M	$7.95	$2.99	-62.37%	Bought +40.00% shares Q3 2022
Medical Care Facilities Encompass Health Corporation Portfolio share: 1.22% Portfolio value: 3.75M Avg. open price: $64.29 Current price: $57.62 P/L: -10.37% N/A Q3 2022	share	1.22%	3.75M	$64.29	$57.62	-10.37%	N/A Q3 2022
Medical Care Facilities Tenet Healthcare Corporation Portfolio share: 1.18% Portfolio value: 3.63M Avg. open price: $52.56 Current price: $44.6 P/L: -15.14% Bought +48.68% shares Q3 2022	share	1.18%	3.63M	$52.56	$44.6	-15.14%	Bought +48.68% shares Q3 2022
REIT—Healthcare Facilities Ventas, Inc. Portfolio share: 1.12% Portfolio value: 3.44M Avg. open price: N/A Current price: $45.46 P/L: N/A N/A Q3 2022	share	1.12%	3.44M	N/A	$45.46	N/A	N/A Q3 2022
Biotechnology Albireo Pharma, Inc. Portfolio share: 1.09% Portfolio value: 3.34M Avg. open price: $25.52 Current price: $22.7 P/L: -11.04% Bought +356.25% shares Q3 2022	share	1.09%	3.34M	$25.52	$22.7	-11.04%	Bought +356.25% shares Q3 2022
Medical Devices Bio-Rad Laboratories, Inc. Portfolio share: 0.95% Portfolio value: 2.91M Avg. open price: $578.39 Current price: $405.79 P/L: -29.84% Sold -56.43% shares Q3 2022	share	0.95%	2.91M	$578.39	$405.79	-29.84%	Sold -56.43% shares Q3 2022
Medical Instruments & Supplies Merit Medical Systems, Inc. Portfolio share: 0.94% Portfolio value: 2.89M Avg. open price: $54.27 Current price: $71.11 P/L: +31.03% Bought +153.27% shares Q3 2022	share	0.94%	2.89M	$54.27	$71.11	+31.03%	Bought +153.27% shares Q3 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 0.83% Portfolio value: 2.54M Avg. open price: $28.11 Current price: $33.96 P/L: +20.82% Bought +50.30% shares Q3 2022	share	0.83%	2.54M	$28.11	$33.96	+20.82%	Bought +50.30% shares Q3 2022
Biotechnology Insmed Incorporated Portfolio share: 0.76% Portfolio value: 2.32M Avg. open price: $27.92 Current price: $19.89 P/L: -28.75% Sold -24.18% shares Q3 2022	share	0.76%	2.32M	$27.92	$19.89	-28.75%	Sold -24.18% shares Q3 2022
Biotechnology Galapagos NV Portfolio share: 0.71% Portfolio value: 2.16M Avg. open price: N/A Current price: $38.92 P/L: N/A Sold -1.14% shares Q3 2022	share	0.71%	2.16M	N/A	$38.92	N/A	Sold -1.14% shares Q3 2022
Biotechnology Adaptimmune Therapeutics plc Portfolio share: 0.63% Portfolio value: 1.92M Avg. open price: $5 Current price: $1.95 P/L: -60.97% Sold -1.95% shares Q3 2022	share	0.63%	1.92M	$5	$1.95	-60.97%	Sold -1.95% shares Q3 2022
Medical Care Facilities Cano Health, Inc. Portfolio share: 0.60% Portfolio value: 1.82M Avg. open price: N/A Current price: $2.09 P/L: N/A N/A Q3 2022	share	0.60%	1.82M	N/A	$2.09	N/A	N/A Q3 2022
Biotechnology Veracyte, Inc. Portfolio share: 0.59% Portfolio value: 1.80M Avg. open price: $39.98 Current price: $27.17 P/L: -32.04% N/A Q3 2022	share	0.59%	1.80M	$39.98	$27.17	-32.04%	N/A Q3 2022
Specialty Chemicals Avantor, Inc. Portfolio share: 0.48% Portfolio value: 1.48M Avg. open price: $36.87 Current price: $22.35 P/L: -39.38% Sold -83.15% shares Q3 2022	share	0.48%	1.48M	$36.87	$22.35	-39.38%	Sold -83.15% shares Q3 2022
Biotechnology Sutro Biopharma, Inc. Portfolio share: 0.48% Portfolio value: 1.48M Avg. open price: $10.25 Current price: $7.39 P/L: -27.93% Sold -25.40% shares Q3 2022	share	0.48%	1.48M	$10.25	$7.39	-27.93%	Sold -25.40% shares Q3 2022
Drug Manufacturers—Specialty & Generic Teva Pharmaceutical Industries Limited Portfolio share: 0.47% Portfolio value: 1.44M Avg. open price: $34.25 Current price: $8.62 P/L: -74.83% Sold -61.02% shares Q3 2022	share	0.47%	1.44M	$34.25	$8.62	-74.83%	Sold -61.02% shares Q3 2022
Medical Care Facilities Option Care Health, Inc. Portfolio share: 0.45% Portfolio value: 1.36M Avg. open price: N/A Current price: $30.22 P/L: N/A N/A Q3 2022	share	0.45%	1.36M	N/A	$30.22	N/A	N/A Q3 2022
Medical Distribution Owens & Minor, Inc. Portfolio share: 0.44% Portfolio value: 1.34M Avg. open price: $42.23 Current price: $20.73 P/L: -50.91% N/A Q3 2022	share	0.44%	1.34M	$42.23	$20.73	-50.91%	N/A Q3 2022
Biotechnology Vaxcyte, Inc. Portfolio share: 0.41% Portfolio value: 1.25M Avg. open price: N/A Current price: $44.33 P/L: N/A N/A Q3 2022	share	0.41%	1.25M	N/A	$44.33	N/A	N/A Q3 2022
Biotechnology Reata Pharmaceuticals, Inc. Portfolio share: 0.20% Portfolio value: 612K Avg. open price: N/A Current price: $39.62 P/L: N/A N/A Q3 2022	share	0.20%	612K	N/A	$39.62	N/A	N/A Q3 2022
Biotechnology Maravai LifeSciences Holdings, Inc. Portfolio share: 0.19% Portfolio value: 580K Avg. open price: N/A Current price: $13.34 P/L: N/A Sold -1.33% shares Q3 2022	share	0.19%	580K	N/A	$13.34	N/A	Sold -1.33% shares Q3 2022
Biotechnology Acumen Pharmaceuticals, Inc. Portfolio share: 0.18% Portfolio value: 555K Avg. open price: N/A Current price: $5.6 P/L: N/A N/A Q3 2022	share	0.18%	555K	N/A	$5.6	N/A	N/A Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 0.18% Portfolio value: 553K Avg. open price: N/A Current price: $92.75 P/L: N/A N/A Q3 2022	share	0.18%	553K	N/A	$92.75	N/A	N/A Q3 2022
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 0.17% Portfolio value: 524K Avg. open price: N/A Current price: $4.45 P/L: N/A N/A Q3 2022	share	0.17%	524K	N/A	$4.45	N/A	N/A Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 0.15% Portfolio value: 446K Avg. open price: N/A Current price: $38.12 P/L: N/A Sold -20.17% shares Q3 2022	share	0.15%	446K	N/A	$38.12	N/A	Sold -20.17% shares Q3 2022
Biotechnology MorphoSys AG Portfolio share: 0.11% Portfolio value: 344K Avg. open price: N/A Current price: $4.22 P/L: N/A N/A Q3 2022	share	0.11%	344K	N/A	$4.22	N/A	N/A Q3 2022
Diagnostics & Research Biodesix, Inc. Portfolio share: 0.05% Portfolio value: 165K Avg. open price: N/A Current price: $1.43 P/L: N/A Sold -0.47% shares Q3 2022	share	0.05%	165K	N/A	$1.43	N/A	Sold -0.47% shares Q3 2022
Drug Manufacturers—Specialty & Generic Athenex, Inc. Portfolio share: 0.05% Portfolio value: 142K Avg. open price: N/A Current price: $0.19 P/L: N/A N/A Q3 2022	share	0.05%	142K	N/A	$0.19	N/A	N/A Q3 2022
Biotechnology Praxis Precision Medicines, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.14 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.14	N/A	Sold -100.00% shares Q3 2022
SPDR S&P 500 ETF Trust Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $431.32 Current price: $400.01 P/L: -7.26% Sold -100.00% shares Q3 2022	put	0.00%	0	$431.32	$400.01	-7.26%	Sold -100.00% shares Q3 2022
SPDR S&P Biotech ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $105.79 Current price: $82.88 P/L: -21.66% Sold -100.00% shares Q3 2022	call	0.00%	0	$105.79	$82.88	-21.66%	Sold -100.00% shares Q3 2022
SPDR S&P Biotech ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $105.79 Current price: $82.88 P/L: -21.66% Sold -100.00% shares Q3 2022	share	0.00%	0	$105.79	$82.88	-21.66%	Sold -100.00% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $121.22 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$121.22	N/A	Sold -100.00% shares Q3 2022
Biotechnology Fate Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $16.28 Current price: $20.4 P/L: +25.27% Sold -100.00% shares Q3 2022	share	0.00%	0	$16.28	$20.4	+25.27%	Sold -100.00% shares Q3 2022
Medical Devices SI-BONE, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $24.19 Current price: $12.08 P/L: -50.06% Sold -100.00% shares Q3 2022	share	0.00%	0	$24.19	$12.08	-50.06%	Sold -100.00% shares Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $116.56 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$116.56	N/A	Sold -100.00% shares Q3 2022
Healthcare Plans Centene Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $64.92 Current price: $86.35 P/L: +33.01% Sold -100.00% shares Q3 2022	share	0.00%	0	$64.92	$86.35	+33.01%	Sold -100.00% shares Q3 2022
Medical Devices Boston Scientific Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $23.35 Current price: $45.42 P/L: +94.54% Sold -100.00% shares Q3 2022	share	0.00%	0	$23.35	$45.42	+94.54%	Sold -100.00% shares Q3 2022
Medical Care Facilities Acadia Healthcare Company, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $85.65 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$85.65	N/A	Sold -100.00% shares Q3 2022
Biotechnology Axsome Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $14.29 Current price: $77.29 P/L: +441.03% Sold -100.00% shares Q3 2022	share	0.00%	0	$14.29	$77.29	+441.03%	Sold -100.00% shares Q3 2022
Medical Devices Zimmer Biomet Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $122.78 Current price: $122.3 P/L: -0.39% Sold -100.00% shares Q3 2022	share	0.00%	0	$122.78	$122.3	-0.39%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $21.67 Current price: $98.48 P/L: +354.45% Sold -100.00% shares Q3 2022	share	0.00%	0	$21.67	$98.48	+354.45%	Sold -100.00% shares Q3 2022
Medical Distribution AmerisourceBergen Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $86.82 Current price: $171.25 P/L: +97.25% Sold -100.00% shares Q3 2022	share	0.00%	0	$86.82	$171.25	+97.25%	Sold -100.00% shares Q3 2022
Biotechnology ADC Therapeutics SA Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $46.81 Current price: $3.52 P/L: -92.48% Sold -100.00% shares Q3 2022	share	0.00%	0	$46.81	$3.52	-92.48%	Sold -100.00% shares Q3 2022
Invesco QQQ Trust Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $287.73 P/L: N/A Sold -100.00% shares Q3 2022	put	0.00%	0	N/A	$287.73	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $39.55 Current price: $124 P/L: +213.53% Sold -100.00% shares Q3 2022	share	0.00%	0	$39.55	$124	+213.53%	Sold -100.00% shares Q3 2022
Biotechnology Incyte Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $103.29 Current price: $84.08 P/L: -18.60% Sold -100.00% shares Q3 2022	share	0.00%	0	$103.29	$84.08	-18.60%	Sold -100.00% shares Q3 2022
Biotechnology Immunic, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $16.46 Current price: $1.34 P/L: -91.86% Sold -100.00% shares Q3 2022	share	0.00%	0	$16.46	$1.34	-91.86%	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies Hologic, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $43.43 Current price: $75.11 P/L: +72.93% Sold -100.00% shares Q3 2022	share	0.00%	0	$43.43	$75.11	+72.93%	Sold -100.00% shares Q3 2022
Biotechnology Global Blood Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $34.58 Current price: $68.49 P/L: +98.04% Sold -100.00% shares Q3 2022	share	0.00%	0	$34.58	$68.49	+98.04%	Sold -100.00% shares Q3 2022

Showing TOP 71 ENDURANT CAPITAL MANAGEMENT LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of ENDURANT CAPITAL MANAGEMENT LP?

The biggest position of the ENDURANT CAPITAL MANAGEMENT LP is INVACARE CORP () with 15.98% portfolio share worth of 49.06M US dollars.

Top 5 ENDURANT CAPITAL MANAGEMENT LP's holdings represent 36.59% of the portfolio:

INVACARE CORP () – 15.98%
Laboratory Corporation of America Holdings (LH) – 6.49%
Humana Inc. (HUM) – 5.17%
Takeda Pharmaceutical Company Limited (TAK) – 4.66%
Baxter International Inc. (BAX) – 4.3%

Who is the portfolio manager of ENDURANT CAPITAL MANAGEMENT LP?

The portfolio manager of the ENDURANT CAPITAL MANAGEMENT LP is .

What is the total asset value of the ENDURANT CAPITAL MANAGEMENT LP portfolio?

ENDURANT CAPITAL MANAGEMENT LP total asset value (portfolio value) is 307.05M US dollars.

Who is ?

is the portfolio manager of the ENDURANT CAPITAL MANAGEMENT LP.

What is (ENDURANT CAPITAL MANAGEMENT LP) fund performance?

ENDURANT CAPITAL MANAGEMENT LP's quarterly performance is -4.21%, annualy -19.02%. In the past 3 years, the value of 's portfolio has increased by +33%. In the past 5 years, the value of the portfolio has increased by +32%.

What is the ENDURANT CAPITAL MANAGEMENT LP CIK?

ENDURANT CAPITAL MANAGEMENT LP's Central Index Key is 0001633055 .

ENDURANT CAPITAL MANAGEMENT LP Holdings

ENDURANT CAPITAL MANAGEMENT LP portfolio value:

ENDURANT CAPITAL MANAGEMENT LP quarter portfolio value change:

ENDURANT CAPITAL MANAGEMENT LP 1 year portfolio value change:

ENDURANT CAPITAL MANAGEMENT LP 3 years portfolio value change:

ENDURANT CAPITAL MANAGEMENT LP 5 years portfolio value change: